Syncona (SYNC) News Today GBX 95.50 +0.20 (+0.21%) As of 02/21/2025 11:55 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Syncona Limited Acquires 150,000 Shares Under Buyback ProgramFebruary 21 at 2:31 AM | tipranks.comSyncona Limited Executes Share Buyback to Enhance Shareholder ValueFebruary 19 at 2:45 AM | tipranks.comSyncona (LON:SYNC) Hits New 12-Month Low - Here's WhySyncona (LON:SYNC) Sets New 1-Year Low - Time to Sell?February 12, 2025 | marketbeat.comSyncona Executes Share Buyback to Optimize Capital StructureFebruary 11, 2025 | tipranks.comSyncona Limited Enhances Capital Structure with Share BuybackFebruary 10, 2025 | tipranks.comSyncona Limited Executes Share Buyback to Strengthen Capital StructureFebruary 7, 2025 | tipranks.comSyncona sees negative nine-month return despite quarterly riseFebruary 6, 2025 | lse.co.ukSyncona investee Achilles plans liquidation and capital returnFebruary 6, 2025 | lse.co.ukSyncona Limited Executes Share Buyback, Impacting Voting RightsFebruary 5, 2025 | tipranks.comSyncona (LON:SYNC) Sets New 52-Week Low - Should You Sell?Syncona (LON:SYNC) Sets New 1-Year Low - Should You Sell?February 4, 2025 | marketbeat.comSyncona Share Chat (SYNC)February 4, 2025 | lse.co.ukSyncona’s Spur Therapeutics Reports Promising Gene Therapy Data in Gaucher Disease TrialFebruary 4, 2025 | tipranks.comSyncona Executes Strategic Share BuybackFebruary 4, 2025 | tipranks.comSyncona Limited Announces Total Voting RightsFebruary 3, 2025 | tipranks.comSyncona Limited Expands Share Buyback ProgrammeJanuary 31, 2025 | tipranks.comSyncona (LON:SYNC) Trading 0.4% Higher - Time to Buy?Syncona (LON:SYNC) Shares Up 0.4% - Still a Buy?January 29, 2025 | marketbeat.comSyncona Limited Executes Share Buyback to Enhance Capital ManagementJanuary 27, 2025 | tipranks.com‘I oversaw the largest investment trust merger in British history – but I missed Nvidia’January 14, 2025 | finance.yahoo.comSyncona (LON:SYNC) Hits New 1-Year Low - Here's What HappenedSyncona (LON:SYNC) Reaches New 1-Year Low - Here's WhyJanuary 7, 2025 | marketbeat.comSyncona (LON:SYNC) Trading Down 2.1% - What's Next?Syncona (LON:SYNC) Shares Down 2.1% - Should You Sell?January 3, 2025 | marketbeat.comSyncona Limited Reports Total Voting Rights for Year-End 2024January 2, 2025 | tipranks.comSyncona Enhances Shareholder Value with Share BuybackDecember 31, 2024 | tipranks.comSyncona: Achilles Announces Sale Of Technology Assets To AstraZeneca - Quick FactsDecember 27, 2024 | markets.businessinsider.comSyncona Limited Updates on Share Buyback ProgramDecember 27, 2024 | tipranks.comAchilles Therapeutics Sells Key Assets to AstraZenecaDecember 27, 2024 | tipranks.comSyncona (LON:SYNC) Stock Price Up 0.4% - Time to Buy?Syncona (LON:SYNC) Stock Price Up 0.4% - Here's What HappenedDecember 12, 2024 | marketbeat.comSyncona’s iOnctura Reports Positive Phase I Results for Roginolisib in Uveal MelanomaDecember 11, 2024 | tipranks.comSyncona Limited Executes Share Buyback as Part of Capital Management StrategyDecember 11, 2024 | tipranks.comSyncona Limited Strengthens Position with Share BuybackDecember 9, 2024 | msn.comSyncona hails positive trial data for new Beacon Therapeutics drugDecember 6, 2024 | lse.co.ukSyncona’s Beacon Reports Promising Trial ResultsDecember 6, 2024 | tipranks.comSyncona Limited Updates on Voting Rights and StrategyDecember 2, 2024 | tipranks.comSyncona Shs GBP Announces Board Committee UpdateNovember 19, 2024 | msn.comSyncona net assets values down; announces new portfolio firm SlingshotNovember 15, 2024 | lse.co.ukSyncona's Autolus wins FDA approval for aggressive leukaemia therapyNovember 12, 2024 | lse.co.ukSyncona’s Autolus Gains FDA Approval for Leukemia TherapyNovember 12, 2024 | msn.comSyncona : Autolus Receives FDA Approval For AUCATZYL In Adults With Relapsed/Refractory B-ALLNovember 12, 2024 | markets.businessinsider.comLondon pre-open: Stocks to rise; jobs data eyedNovember 11, 2024 | lse.co.ukKesmalea Therapeutics Appoints Robert Johnson as CEO To Lead Development of New Class of Oral, CNS Penetrant Protein DegradersNovember 8, 2024 | finance.yahoo.comSyncona Limited Boosts Share Value with BuybackNovember 4, 2024 | msn.comSyncona (LON:SYNC) Share Price Crosses Below Fifty Day Moving Average - Here's WhySyncona (LON:SYNC) Stock Price Crosses Below 50 Day Moving Average - What's Next?November 1, 2024 | marketbeat.comPurespring Therapeutics presents new preclinical data on novel gene therapy for IgA Nephropathy at ASN Kidney Week 2024October 28, 2024 | tmcnet.comSyncona celebrates investee's positive trial data on Gaucher diseaseOctober 23, 2024 | lse.co.ukNYBC Ventures Announces Formation of Board of ManagersOctober 16, 2024 | tmcnet.comSyncona (LON:SYNC) Reaches New 1-Year Low - Here's WhySyncona (LON:SYNC) Sets New 12-Month Low - What's Next?October 15, 2024 | marketbeat.comPurespring raises $105M to advance gene therapy for kidney diseaseOctober 9, 2024 | finance.yahoo.comSyncona makes further investment in Purespring TherapeuticsOctober 9, 2024 | lse.co.ukPurespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseasesOctober 9, 2024 | markets.businessinsider.comResolution scores $83m to develop macrophage cell therapiesOctober 3, 2024 | finance.yahoo.comSyncona makes further investment in Resolution TherapeuticsOctober 3, 2024 | lse.co.uk Get Syncona News Delivered to You Automatically Sign up to receive the latest news and ratings for SYNC and its competitors with MarketBeat's FREE daily newsletter. Email Address SYNC Media Mentions By Week SYNC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SYNC News Sentiment▼0.390.68▲Average Financial Services News Sentiment SYNC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SYNC Articles This Week▼21▲SYNC Articles Average Week Get Syncona News Delivered to You Automatically Sign up to receive the latest news and ratings for SYNC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HICL News Today INPP News Today CTY News Today QLT News Today CLDN News Today JAM News Today SSON News Today RAT News Today TRIG News Today TEM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:SYNC) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWatch This Robotics Demo Before March 17thJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syncona Please log in to your account or sign up in order to add this asset to your watchlist. Share Syncona With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
